P210 Interim results from the RESPOND study evaluating nusinersen in children with spinal muscular atrophy previously treated with onasemnogene abeparvovec

J. Parsons, N. Kuntz,J. Brandsema, C. Proud, R. Finkel,K. Swoboda, R. Masson,R. Foster,Y. Liu, C. Makepeace, S. Singhi, A. Paradis,Z. Berger, S. Rane, K. Somera-Molina

Neuromuscular Disorders(2023)

引用 0|浏览4
暂无评分
关键词
spinal muscular atrophy,nusinersen,p210 interim results,onasemnogene
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要